Research programme: submicron migraine therapeutics - iCeutica

Drug Profile

Research programme: submicron migraine therapeutics - iCeutica

Alternative Names: ICE-1209; ICE-1210; ICE-1211

Latest Information Update: 01 Oct 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator iCeutica
  • Class Tryptamines
  • Mechanism of Action Serotonin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Migraine

Most Recent Events

  • 01 Oct 2014 Research programme: submicron migraine therapeutics - iCeutica is available for licensing as of 01 Oct 2014. http://www.iceutica.com/
  • 01 Oct 2014 Preclinical trials in Migraine in USA (Intranasal) prior to October 2014
  • 01 Oct 2014 Preclinical trials in Migraine in USA (Sublingual) prior to October 2014
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top